Vorobeychik, Galina
University of British Columbia · Fraser Health
3 papers on CoChatORCID 0000-0002-5005-7158
Most cited papers
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes
Kang, H., Metz, L., Traboulsee, A., Eliasziw, M., Zhao, G., Cheng, Y., Zhao, Y., Li, D., the Minocycline in CIS Study Group, Traboulsee, A., et al. (2014) · Multiple Sclerosis Journal
Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills
Cited by 25
- Verified
Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis
Allanach, J. R., Fettig, N. M., Hardman, B. K., Rosen, A. R., Fan, V., Chung, C., Goldberg, E. J., Morse, Z. J., Shanina, I., Vorobeychik, G., et al. (2025) · Science Advances
Multiple Sclerosis Research StudiesT-cell and B-cell Immunology
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free